Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Journal of Medical Economics
|
April 14, 2016
Examining the association between pain severity and quality-of-life, work-productivity loss, and healthcare resource use among European adults diagnosed with pain
Edward A Witt, James Kenworthy, Gina Isherwood, et al.
Pharmacoeconomics
|
December 9, 2016
Benefits, Challenges and Potential Strategies of Open Source Health Economic Models
William C N Dunlop, Nicola Mason, James Kenworthy, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|
January 1, 1972
[Hydrolase activity for N-substituted aminoacyl-tRNA in ribosomes and supernatant fractions from human tissues and tumors]
R Neth, N Dunlop, G Heller-Schöch, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 23, 2018
Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom
Sue Langham, Antony Wright, James Kenworthy, et al.
Cancer Management and Research
|
November 19, 2021
The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
Michael Patrick Lux, Oriana Ciani, William C N Dunlop, et al.
Addiction Science & Clinical Practice
|
February 26, 2017
A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence
Mersha Chetty, James J Kenworthy, Sue Langham, et al.
Journal of Medical Economics
|
June 9, 2018
Cost-effectiveness modeling for neuropathic pain treatments: investigating the relative importance of parameters using an open-source model
Matthew Hirst, Matthew W Bending, Gianluca Baio, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1997
Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes
J D Ahlers, N Dunlop, D W Alling, et al.
Journal of Medical Economics
|
May 11, 2017
Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study
James Kenworthy, Yunni Yi, Antony Wright, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 14, 2018
Cost-utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort
Rebecca Forster, Aran Ratcliffe, Megan Lewis, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Journal of Medical Economics
|
April 14, 2016
Examining the association between pain severity and quality-of-life, work-productivity loss, and healthcare resource use among European adults diagnosed with pain
Edward A Witt, James Kenworthy, Gina Isherwood, et al.
Pharmacoeconomics
|
December 9, 2016
Benefits, Challenges and Potential Strategies of Open Source Health Economic Models
William C N Dunlop, Nicola Mason, James Kenworthy, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|
January 1, 1972
[Hydrolase activity for N-substituted aminoacyl-tRNA in ribosomes and supernatant fractions from human tissues and tumors]
R Neth, N Dunlop, G Heller-Schöch, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 23, 2018
Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom
Sue Langham, Antony Wright, James Kenworthy, et al.
Cancer Management and Research
|
November 19, 2021
The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
Michael Patrick Lux, Oriana Ciani, William C N Dunlop, et al.
Addiction Science & Clinical Practice
|
February 26, 2017
A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence
Mersha Chetty, James J Kenworthy, Sue Langham, et al.
Journal of Medical Economics
|
June 9, 2018
Cost-effectiveness modeling for neuropathic pain treatments: investigating the relative importance of parameters using an open-source model
Matthew Hirst, Matthew W Bending, Gianluca Baio, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1997
Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes
J D Ahlers, N Dunlop, D W Alling, et al.
Journal of Medical Economics
|
May 11, 2017
Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study
James Kenworthy, Yunni Yi, Antony Wright, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 14, 2018
Cost-utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort
Rebecca Forster, Aran Ratcliffe, Megan Lewis, et al.
Page
of 4